Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Evaluate Safety and Efficacy of Etoricoxib in Patients With Parkinson's Disease Treated With Conventional Treatment

NCT07370532 is registered in ClinicalTrials.gov with Ihab Elsayed Hassan as lead sponsor.

NCT NCT07370532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07370532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Evaluate Safety and Efficacy of Etoricoxib in Patients With Parkinson's Disease Treated With Conventional Treatment
Lead sponsor
Ihab Elsayed Hassan
Phase
Phase 2
Overall status
Recruiting
Start date
January 30, 2026
Completion date
November 20, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease